Chelation therapy for iron overload in sickle cell and thalassaemia

Size: px
Start display at page:

Download "Chelation therapy for iron overload in sickle cell and thalassaemia"

Transcription

1 Networked Services Chelation therapy for iron overload in sickle cell and thalassaemia Information for adult patients at King s College Hospital only This leaflet answers some of the questions you may have about the drugs we use to treat iron overload. It explains how they work and the benefits and risks. It contains important information so please read it carefully. If you have any questions or concerns, please do not hesitate to speak to your haematology doctor. 1

2 What is iron overload? When you have regular blood transfusions to treat sickle cell or thalassaemia conditions, large amounts of iron build up in your body (iron overload). People with certain types of thalassaemia can have a build up of iron without having repeated transfusions. Excess iron can damage organs such as the heart, liver, pancreas and the hormone glands. Treatment for iron overload is called iron chelation. We assess you when you have had more than 20 units of red blood cells and treatment starts when needed. What are the symptoms? Symptoms of iron overload depend on where the extra iron is located in your body. Sometimes you only have symptoms when iron overload is severe. Too much iron can damage: The heart: It can cause heart failure and irregular heart rhythms. Symptoms include feeling very tired, breathless and not being able to do as much physical activity. The liver: It can cause scarring of the liver (cirrhosis). Symptoms include loss of appetite, nausea, tiredness, jaundice (yellowing of the skin and whites of eyes) and itchy skin. The pancreas: It can lead to diabetes. Diabetes is irreversible and treated with insulin. Symptoms include feeling very thirsty, very tired, urinating more often (especially at night) and weight loss. Hormone glands: The thyroid may slow down which means it does not produce enough chemicals (hormones). Symptoms of an underactive thyroid include tiredness, weight gain, depression, dry skin and hair. 2

3 Sex hormone glands: You may not produce enough sex hormones (men: testes, women: ovaries). This can cause fertility problems and difficulties with the development of secondary sexual characteristics (features you develop during puberty). For example, the development of breasts for females, and for males, the deepening of voice, and the growth of facial hair and body hair). Women: it can cause weak bones (osteoporosis) and your menstrual periods may be delayed, irregular or stop. Men: it can affect your testosterone levels. This can cause sexual dysfunction, increased body fat and reduced muscle mass. It is important to treat iron overload as early as possible to reduce and prevent damage. How do you measure iron overload? There are different types of tests to measure iron levels in your blood. These include: Scans: MRI scans of your liver and heart are very useful to assess whether you have a build-up of iron. A special type of MRI scan will show how your heart is functioning. Blood tests: One of the first tests that we do, measures your ferritin level. Ferritin is a protein that shows how much iron is stored in the body. If the amount of ferritin in your body continues to rise, it could mean that you have a build-up of iron. We will give you medication to lower your ferritin level. 3

4 A range of other tests find out how your organs are functioning and if you have a build-up of iron. These tests may be for thyroid function, liver function, sex hormone level, some vitamin and mineral levels, screening tests for diabetes and adrenal gland problems. We will give you more information about any other tests you have. What are the benefits? Extra iron is removed from your body to prevent damage to your organs and glands. What are the risks? There are different risks and side effects depending on the type of medication you take. Please read this leaflet for the risks of each medication. If you do not have treatment, iron will continue to build up in your organs and glands, and cause damage. Are there any alternatives? There are no alternatives to iron chelation. How is iron overload treated? We use medicine (the iron chelator) to remove the extra iron. If you already have iron overload, it will take longer for the iron to leave your body. It is very important to take your medication regularly so you have no extra iron in your body. 4

5 What are the different medications available for chelation therapy? We use three types of medication: Deferisarox (Exjade) Desferrioxamine (Desferal) Deferiprone (Ferriprox). Your doctor will decide which type of chelation treatment is best for you. This depends on where the extra iron is and the organ it is affecting. Is important that you take your medication as prescribed, and check the expiry date. Deferasirox (Exjade) Desferasirox is especially effective for removing iron from the liver. Important- do not use deferasirox if: You think you may be pregnant; tell your doctor as soon as possible You are breastfeeding. How do I take it? By mouth as a dispersible (quick to dissolve) tablet. Do not chew or swallow them whole. You should put the tablet in water, orange juice or apple juice. You should take it on an empty stomach at least 30 minutes before you eat, at the same time each day, to lower side effects. How often should I take desferasirox? Once a day. If you occasionally miss a dose, it will not cause any problems, but if you often miss doses, you could develop other 5

6 medical problems. If you miss a dose, don t take it when you remember - wait until your next dose is due. If you take too much, go to your local Emergency Department (A&E) immediately. What are the side effects? Very common It can affect the function of your kidneys. You will have regular blood tests so that we can closely monitor your kidneys. Common Nausea, sickness and diarrhoea; these usually improve over time. If you have diarrhoea often, tell your doctor so that they can give you anti-diarrhoea medication. Stomach pain and indigestion Rashes. This usually resolves on its own Changes in liver function tests. We will monitor this. Uncommon Black stools Tiredness Problems with vision Problems with hearing. If you vomit blood and/or have black stools, stop taking this medicine immediately and go to your local ED straight away. It can lower the number of different types of blood cells. If it lowers one of the types of white blood cells, it can reduce your body s ability to fight infection. You will have regular blood tests so that we can closely monitor your blood counts. 6

7 If you have any of the following symptoms, your white blood cell count may be low and you could have an infection. Please contact the Supportive Therapy Unit (in working hours) or your local ED (out of hours) immediately. a high temperature (above 38 C) chills and shivering sore throat mouth ulcers. If you notice bruising, bleeding, unusual tiredness or weakness, it could mean you have a low blood count. Go to your local ED immediately. It is important that you have regular hearing and eye monitoring checks every year, and go to all of your appointments Desferrioxamine (Desferal) Do not use deferrioxamine if: You are allergic to any of the ingredients in deferrioxamine You think you may be pregnant; tell your doctor as soon as possible. How do I take it? This is given as an injection under the skin (subcutaneously) using a special pump. Your doctor may decide that you should have this medicine over a period of time, through a vein. 7

8 How often should I take desferrioxamine? You need to use the pump continuously for at least 8-10 hours, three-seven times a week. However, your doctor will decide your dose and how often you need to take it. For treatment to be effective, you must make sure that the pump is properly connected and turned on as discussed with your nurse. If you occasionally miss a dose, it will not cause any problems, but if you often miss doses, you could develop other medical problems. If you miss a dose, don t take it when you remember - wait until your next dose is due. If you take too much, go to your local Emergency Department (A&E) immediately. What are the side effects? Some people have no side effects. However, some possible side effects include: Very Common Skin irritation or blisters where the needle was put in Aching muscles or joints. Common Nausea Uncommon Sickness Ringing in your ears (tinnitus). Rare Problems with your vision Some bacteria grow on the extra iron that is removed. Yersinia bacteria can cause abdominal pain, fever, diarrhoea and vomiting. If you get any of these symptoms, stop your treatment immediately and contact the Supportive Therapy Unit (in working hours) or go to your local ED if out of hours. 8

9 It is important that you have regular hearing and eye monitoring checks every year, and go to all of your appointments. How do I store desferrioxamine? Keep in the fridge in the original packaging Do not freeze Keep out of reach of children. Deferiprone (Ferriprox) Deferiprone is particularly effective for removing iron from the heart. Important- do not use deferiprone if: You are allergic to any of the ingredients in deferiprone You are breastfeeding You plan to become pregnant or think you may be pregnant, as it can affect your unborn baby You are having sexual intercourse without contraception. We advise women who have periods to use contraception. How do I take it? By mouth (orally) as a tablet or liquid solution. How often should I take deferiprone? Three times a day. It is important to only take the dose prescribed. Take it with some water or other liquid. If you occasionally miss a dose, it will not cause any problems, but if you often miss doses, you could develop other medical problems. If you miss a dose, don t take it when you remember - wait until your next dose is due. If you take too much, go to your local Emergency Department (A&E) immediately. 9

10 What are the side effects? It can lower one of the types of white blood cells, which reduces your body s ability to fight infection. You will have regular blood tests so that we can closely monitor your levels. If you have any of the following symptoms, your white blood cell count may be low and you could have an infection. Please contact the Supportive Therapy Unit (in working hours) or go to your local ED (out of hours) immediately. a high temperature (above 38 C) sore throat mouth ulcers. Very Common Red/brown urine. This is normal as the excess iron (a red/brown colour) comes out in your urine. Nausea and sickness - you can often reduce this by taking your tablets with your meals Stomach pain. Common Joint pain Increased appetite Low white blood cell count. The information in this leaflet is to be used as a guide only. Please discuss the specific details of your treatment with your doctor and remember to ask if there is anything that you are not sure of. 10

11 Who can I contact with queries and concerns? If you have questions about your treatment, please contact: Chengetai Muzah, Clinical Nurse Specialist Tel: or Dr Moji Awogbade, Consultant haematologist Tel: Supportive Therapy Unit Tel: / 2963 Where can I get more information? Sickle Cell Society UK Thalassaemia Society Sharing your information We have teamed up with Guy s and St Thomas Hospitals in a partnership known as King s Health Partners Academic Health Sciences Centre. We are working together to give our patients the best possible care, so you might find we invite you for appointments at Guy s or St Thomas. To make sure everyone you meet always has the most up-to-date information about your health, we may share information about you between the hospitals. Care provided by students We provide clinical training where our students get practical experience by treating patients. Please tell your doctor or nurse if you do not want students to be involved in your care. Your treatment will not be affected by your decision. 11

12 PALS The Patient Advice and Liaison Service (PALS) is a service that offers support, information and assistance to patients, relatives and visitors. They can also provide help and advice if you have a concern or complaint that staff have not been able to resolve for you. The PALS office is located on the ground floor of the Hambleden Wing, near the main entrance on Bessemer Road - staff will be happy to direct you. Tel: Fax: kch-tr.pals@nhs.net You can also contact us by using our online form at If you would like the information in this leaflet in a different language or format, please contact PALS on Corporate Comms: 1088 PL695.2 September 2015 Review date August 2018

Desferrioxamine chelation therapy

Desferrioxamine chelation therapy The information in this leaflet is general and is intended to be a guide only. Please discuss the specific details of your treatment with your GP/doctor. What is desferrioxamine? Desferrioxamine, also

More information

Gemcitabine and Cisplatin (urology)

Gemcitabine and Cisplatin (urology) Gemcitabine and Cisplatin Gemcitabine and Cisplatin (urology) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce

More information

Intravenous sedation for dental treatment

Intravenous sedation for dental treatment Intravenous sedation for dental treatment Information for patients This leaflet aims to help you understand the treatment you are going to have and contains answers to many commonly asked questions. If

More information

Sorafenib (Nexavar ) For thyroid carcinoma

Sorafenib (Nexavar ) For thyroid carcinoma Sorafenib (Nexavar ) for thyroid carcinoma Sorafenib (Nexavar ) For thyroid carcinoma This leaflet is offered as a guide to you and your family. Sorafenib is a type of anti-cancer treatment called a targeted

More information

Important safety information to minimise the risk of immune-related adverse reactions

Important safety information to minimise the risk of immune-related adverse reactions Your Guide to KEYTRUDA (pembrolizumab) Important safety information to minimise the risk of immune-related adverse reactions Information for Patients This medicine is subject to additional monitoring.

More information

Weekly standard dose. Paclitaxel (Taxol) and carboplatin

Weekly standard dose. Paclitaxel (Taxol) and carboplatin paclitaxel (taxol) and carboplatin Paclitaxel (Taxol) and carboplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Pentostatin (Nipent )

Pentostatin (Nipent ) Pentostatin (Nipent ) Pentostatin (Nipent ) This leaflet is offered as a guide to you and your family. Your treatment will be fully explained by your doctor or nurse, who will be happy to answer any questions.

More information

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine. Bendamustine Bendamustine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours.

Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours. Cisplatin & Mitomycin C Cisplatin & Mitomycin C This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

Oral cyclophosphamide in ovarian cancer

Oral cyclophosphamide in ovarian cancer Oral cyclophosphamide in ovarian cancer Oral cyclophosphamide in ovarian cancer This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Ibrutinib (Imbruvica )

Ibrutinib (Imbruvica ) Ibrutinib (Imbruvica) Ibrutinib (Imbruvica ) This leaflet is offered as a guide to you and your family. Ibrutinib is a type of anti-cancer treatment called a targeted therapy. The aim of this treatment

More information

Vinblastine (Lymphoma)

Vinblastine (Lymphoma) Vinblastine (Lymphoma) Vinblastine (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

Myeloma Haematology and Transplant Unit

Myeloma Haematology and Transplant Unit BCD Myeloma Haematology and Transplant Unit BCD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

University College Hospital

University College Hospital University College Hospital Exjade treatment for iron overload North Central London Haemoglobinopathy Network jointly with Whittington Health, Royal Free London and Luton and Dunstable NHS Foundation Trust

More information

Gemcitabine and carboplatin (Breast)

Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Brentuximab vedotin. Brentuximab vedotin

Brentuximab vedotin. Brentuximab vedotin Brentuximab vedotin Brentuximab vedotin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Gemcitabine and carboplatin (Lung)

Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Ceritinib (Zykadia )

Ceritinib (Zykadia ) (Ceritinib (Zykadia ) (Xalkori) Ceritinib (Zykadia ) This leaflet is offered as a guide to you and your family. Ceritinib (Zykadia ) is a type of anti-cancer treatment called a targeted therapy. The aim

More information

Pemetrexed (Alimta )

Pemetrexed (Alimta ) Pemetrexed (Alimta ) Pemetrexed (Alimta ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets ChIVPP ChIVPP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

Paclitaxel (Taxol) and carboplatin

Paclitaxel (Taxol) and carboplatin Paclitaxel (Taxol) and carboplatin Paclitaxel (Taxol) and carboplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Nivolumab. Nivolumab

Nivolumab. Nivolumab Nivolumab Nivolumab This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people immunotherapy may reduce the risk of the cancer coming back, for

More information

Cisplatin and gemcitabine (GI)

Cisplatin and gemcitabine (GI) Cisplatin and gemcitabine (GI) Cisplatin and gemcitabine (GI) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce

More information

Pazopanib (Votrient ) oral for renal tumours

Pazopanib (Votrient ) oral for renal tumours Pazopanib (Votrient )oral for renal tumours Pazopanib (Votrient ) oral for renal tumours This leaflet is offered as a guide to you and your family. Pazopanib (Votrient ) is a type of medicine called a

More information

Pemetrexed (Alimta ) and cisplatin

Pemetrexed (Alimta ) and cisplatin Pemetrexed (Alimta ) and cisplatin Pemetrexed (Alimta ) and cisplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

The treatment is given every 3 weeks for 6 to 8 cycles.

The treatment is given every 3 weeks for 6 to 8 cycles. R-CVP R-CVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it

More information

Sacroiliac joint injections

Sacroiliac joint injections Sacroiliac joint injections Information for patients This information leaflet explains sacroiliac joint injections. It includes the risks, the benefits and the alternatives. If you have any questions or

More information

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer)

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer) Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer) The possible benefits of treatment vary; for some people chemotherapy may reduce the

More information

Epirubicin. Epirubicin

Epirubicin. Epirubicin Epirubicin Epirubicin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for

More information

Vinorelbine (Oral) Oral Vinorelbine

Vinorelbine (Oral) Oral Vinorelbine Oral Vinorelbine Vinorelbine (Oral) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming

More information

MACE. Etoposide via an infusion (drip) over 1 hour, once a day for 5 days

MACE. Etoposide via an infusion (drip) over 1 hour, once a day for 5 days MACE MACE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Oral Etoposide (Lymphoma)

Oral Etoposide (Lymphoma) Oral Etoposide (Lymphoma) Oral Etoposide (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk

More information

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre High dose melphalan conditioning for autologous transplant (inpatient) High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre This leaflet is offered as a guide

More information

ALL Consolidation (cycles 1-4)

ALL Consolidation (cycles 1-4) ALL Consolidation (Cycles 1-4) ALL Consolidation (cycles 1-4) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce

More information

Gemcitabine and carboplatin (Lung)

Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Bronchoscopy. Information for patients at King s College Hospital only. Confirming your identity

Bronchoscopy. Information for patients at King s College Hospital only. Confirming your identity Bronchoscopy Information for patients at King s College Hospital only Confirming your identity Before you have a treatment or procedure, our staff will ask you your name and date of birth and check your

More information

Doxorubicin & Ifosfamide

Doxorubicin & Ifosfamide Doxorubicin & Ifosfamide Doxorubicin & Ifosfamide This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of

More information

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes GCVP GCVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Alectinib (Alecensa ) Alectinib (Alecensa )

Alectinib (Alecensa ) Alectinib (Alecensa ) Alectinib (Alecensa ) Alectinib (Alecensa ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people, treatment may reduce the risk of the cancer

More information

Paclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Paclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour. Paclitaxel (Taxol) Paclitaxel (Taxol) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Chronic hepatitis B virus (HBV)

Chronic hepatitis B virus (HBV) Chronic hepatitis B virus (HBV) Information for patients This leaflet explains chronic hepatitis B virus, including how you may have become infected, the main symptoms and how it is treated. If you have

More information

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas Capecitabine chemotherapy and concurrent radiotherapy to the pancreas Capecitabine chemotherapy and concurrent radiotherapy to the pancreas This leaflet is offered as a guide to you and your family. You

More information

Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

Methotrexate. You will have a routine blood test before the start of each cycle of treatment. Methotrexate Methotrexate This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

455 Pemetrexed (Alimta ) cisplatin Page 1 of 6

455 Pemetrexed (Alimta ) cisplatin Page 1 of 6 Pemetrexed (Alimta ) and cisplatin Pemetrexed (Alimta ) and cisplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours VIDE VIDE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour. Myocet Myocet This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks. VDC IE VDC IE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles.

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles. ABVD ABVD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

tumours tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours

tumours tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours tumours tumours Temozolomide and capecitabine for pancreatic neuroendocrine tumours This leaflet is offered as a guide to you and your

More information

Myeloma Haematology and Transplant Unit CTD1

Myeloma Haematology and Transplant Unit CTD1 CTD1 Myeloma Haematology and Transplant Unit CTD1 This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of

More information

Cisplatin and Capecitabine

Cisplatin and Capecitabine Cisplatin and Capecitabine Cisplatin and Capecitabine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk

More information

Mitomycin C and Fluorouracil

Mitomycin C and Fluorouracil Mitomycin C and Fluorouracil Mitomycin C and Fluorouracil This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the

More information

Obinutuzumab (lymphoma) Obinutuzumab (lymphoma)

Obinutuzumab (lymphoma) Obinutuzumab (lymphoma) Obinutuzumab (lymphoma) Obinutuzumab (lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of this treatment vary: for some people, this immune therapy may reduce

More information

Your treatment. 240 BEP 3 Days Page 1 of 6

Your treatment. 240 BEP 3 Days Page 1 of 6 BEP - 3 Days BEP - 3 Days This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC)

Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC) Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC) Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC) This leaflet is offered as a guide to you and your family. The possible benefits of treatment

More information

How Entecavir GH Works

How Entecavir GH Works entecavir monohydrate tablets ENTECAVIR GH Tablets Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking. This leaflet answers some common questions about. It

More information

Docetaxel (Taxotere) with GCSF

Docetaxel (Taxotere) with GCSF Docetaxel (Taxotere) with GCSF Docetaxel (Taxotere) with GCSF for hormone This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Methotrexate. Information for patients. Paediatric Rheumatology. Feedback

Methotrexate. Information for patients. Paediatric Rheumatology. Feedback Feedback We appreciate and encourage feedback. If you need advice or are concerned about any aspect of care or treatment please speak to a member of staff or contact the Patient Advice and Liaison Service

More information

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally. Afatinib (Giotrif) Afatinib (Giotrif ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Erlotinib (Tarceva )

Erlotinib (Tarceva ) Erlotinib (Tarceva ) Erlotinib (Tarceva ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Treatment FLAG. An information guide

Treatment FLAG. An information guide TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Treatment FLAG An information guide Treatment FLAG This leaflet is offered as a guide to you and your family. The possible benefits of treatment

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers Medication Information Sheet (pack li TAX ell) This document provides general information about your medication. It does not replace the advice of your health care professional. Always discuss your therapy

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET PROSTATIN (OCTREOTIDE ACETATE INJECTION 10mcg, 50mcg) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.

More information

Fluorouracil and calcium folinate (Includes MdG (Modified degramont))

Fluorouracil and calcium folinate (Includes MdG (Modified degramont)) Fluorourcil and calcium folinate Fluorouracil and calcium folinate (Includes MdG (Modified degramont)) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary;

More information

system to help fight cancer Working with your immune

system to help fight cancer Working with your immune KEYTRUDA Working with your immune system to help fight cancer www.fightcancer.co.nz CONTACT DETAILS Your Oncologist/Specialist Name Phone Phone (after hours) Your Specialist Nurse Name Phone Phone (after

More information

1. and it is more than 12 hours until your next dose, take the missed dose and continue with your normal schedule

1. and it is more than 12 hours until your next dose, take the missed dose and continue with your normal schedule Everolimus Everolimus (Afinitor ) for pancreatic neuroendocrine tumours This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

WEB intracranial aneurysm device for treating cerebral aneurysms

WEB intracranial aneurysm device for treating cerebral aneurysms WEB intracranial aneurysm device for treating cerebral aneurysms Information for patients This booklet explains how the WEB device is used to treat cerebral (brain) aneurysms, and the benefits and risks

More information

Myeloma Haematology and Transplant Unit MPT

Myeloma Haematology and Transplant Unit MPT MPT Myeloma Haematology and Transplant Unit MPT This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

IVAC IVAC (Lymphoma) 1277 IVAC (Lymphoma) Page 1 of 6

IVAC IVAC (Lymphoma) 1277 IVAC (Lymphoma) Page 1 of 6 IVAC IVAC (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for

More information

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Carbamazepine. For the Treatment of Pain

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Carbamazepine. For the Treatment of Pain NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Carbamazepine For the Treatment of Pain This information is not intended to replace your doctor s

More information

HERNOVIR 200 mg tablets

HERNOVIR 200 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

Eloxatin Oxaliplatin concentrated solution for injection

Eloxatin Oxaliplatin concentrated solution for injection Eloxatin Oxaliplatin concentrated solution for injection Consumer Medicine Information Please read this leaflet before you are given this medicine. What is in this leaflet This leaflet answers some common

More information

Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients

Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients This booklet has been written to give you more information about bevacizumab (commonly known as Avastin). This

More information

Abemaciclib (Verzenios ) Abemaciclib (Verzenios )

Abemaciclib (Verzenios ) Abemaciclib (Verzenios ) Abemaciclib (Verzenios ) Abemaciclib (Verzenios ) Abemaciclib is a targeted (biological) therapy. This group of drugs block the growth and spread of cancer. They target and interfere with processes in

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen Sugar Free 125mg/5ml and 250mg/5ml Powder for Oral Solution Phenoxymethylpenicillin Read all of this leaflet carefully before you start taking this medicine

More information

Package Leaflet: Information for the User

Package Leaflet: Information for the User Package Leaflet: Information for the User Imuran Tablets Azathioprine Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you

More information

Inlyta (axitinib) for Kidney Cancer

Inlyta (axitinib) for Kidney Cancer Inlyta (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg taken twice a day How

More information

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 of a 28 day cycle. You will have 2, 3 or 6 cycles.

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 of a 28 day cycle. You will have 2, 3 or 6 cycles. ABVD ABVD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Cisplatin and radiotherapy to the

Cisplatin and radiotherapy to the Cisplatin and radiotherapy to the head and neck Cisplatin and radiotherapy to the head and neck This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some

More information

METHYLDOPA 250 mg Film-coated Tablets

METHYLDOPA 250 mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions Nivolumab Other Names: Opdivo About this Drug Nivolumab is used to treat cancer. It is given in the vein (IV). Possible Side Effects (More Common) Bone marrow depression. This is a decrease in the number

More information

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. CISPLATIN INJECTION CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Cisplatin Injection. It does not contain all the available information. It does

More information

Dabrafenib and Trametinib

Dabrafenib and Trametinib Dabrafenib and Trametinib Dabrafenib and Trametinib This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary. This treatment aims to control the cancer and its

More information

system to help fight cancer Working with your immune

system to help fight cancer Working with your immune KEYTRUDA Working with your immune system to help fight cancer www.fightcancer.co.nz CONTACT DETAILS Your Oncologist/Specialist ABOUT About KEYTRUDA How KEYTRUDA works Name How KEYTRUDA works with your

More information

Dabrafenib (Tafinlar )

Dabrafenib (Tafinlar ) Dabrafenib (Tafinlar ) Dabrafenib (Tafinlar ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary. This treatment aims to control the cancer and its symptoms.

More information

Eribulin (Halaven ) Treatment is given on Day 1 and Day 8 of a 21-day cycle.

Eribulin (Halaven ) Treatment is given on Day 1 and Day 8 of a 21-day cycle. Eribulin (Halaven ) Eribulin (Halaven ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Capecitabine (breast)

Capecitabine (breast) Capecitabine (breast) Capecitabine (breast) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Managing persistent pain

Managing persistent pain Managing persistent pain Information for patients This leaflet has been produced to help you understand pain and why it persists. It also explores ways that may help you manage persistent pain. 1 What

More information

Treatment FLAG-IDA. An information guide

Treatment FLAG-IDA. An information guide TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Treatment FLAG-IDA An information guide Treatment FLAG-IDA This leaflet is offered as a guide to you and your family. The possible benefits

More information

High dose cytarabine (Lymphoma)

High dose cytarabine (Lymphoma) High dose cytarabine High dose cytarabine (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk

More information

PRIMAXIN Imipenem/Cilastatin sodium

PRIMAXIN Imipenem/Cilastatin sodium PRIMAXIN Imipenem/Cilastatin sodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PRIMAXIN. It does not contain all the available information. It

More information

PATIENT INFORMATION BOOKLET

PATIENT INFORMATION BOOKLET PATIENT INFORMATION BOOKLET GETTING STARTED WITH YOUR MEDICINES TIVICAY (dolutegravir) + lamivudine Tivicay is subject to additional monitoring. This will allow quick identification of new safety information.

More information

Moving forward with your epilepsy treatment

Moving forward with your epilepsy treatment Moving forward with your epilepsy treatment Answers to frequently asked questions about Episenta (Prolonged release sodium valproate) for patients prescribed this treatment This information is not a substitute

More information

Sofosbuvir, Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C

Sofosbuvir, Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Sofosbuvir, Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Department of Hepatology Digestive Diseases Centre Patient Information This leaflet is designed to give you important information

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION BAVENCIO (buh-ven-see-oh) Avelumab for Injection Solution for Intravenous Infusion Read this carefully before you start

More information

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Dexamethasone Other Names: Decadron About This Drug Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Possible Side Effects (More Common) Increased

More information

Package Leaflet: Information for the User

Package Leaflet: Information for the User Package Leaflet: Information for the User KLEAN-PREP 69g Sachet Powder for Oral Solution Macrogol 3350, Sodium sulphate anhydrous, Sodium bicarbonate, Sodium chloride and Potassium chloride Read all of

More information